Molecular subgroup of primary prostate cancer presenting with metastatic biology.
Authors
Walker, SKnight, L
McCavigan, A
Logan, G
Berge, V
Sherif, A
Pandha, H
Warren, A
Davidson, C
Uprichard, A
Blayney, J
Price, B
Jellema, G
Steele, C
Svindland, A
McDade, S
Eden, C
Foster, C
Mills, I
Neal, D
Mason, M
Kay, E
Waugh, D
Harkin, D
Watson, R
Clarke, Noel W
Kennedy, R
Affiliation
Centre for Cancer Research and Cell Biology, Queen's University Belfast, Belfast, UKIssue Date
2017-04-10
Metadata
Show full item recordAbstract
Approximately 4-25% of patients with early prostate cancer develop disease recurrence following radical prostatectomy.Citation
Molecular subgroup of primary prostate cancer presenting with metastatic biology. 2017, Eur UrolJournal
European UrologyDOI
10.1016/j.eururo.2017.03.027PubMed ID
28408174Type
ArticleLanguage
enISSN
1873-7560ae974a485f413a2113503eed53cd6c53
10.1016/j.eururo.2017.03.027
Scopus Count
Collections
Related articles
- A Biopsy-based 17-gene Genomic Prostate Score as a Predictor of Metastases and Prostate Cancer Death in Surgically Treated Men with Clinically Localized Disease.
- Authors: Van Den Eeden SK, Lu R, Zhang N, Quesenberry CP Jr, Shan J, Han JS, Tsiatis AC, Leimpeter AD, Lawrence HJ, Febbo PG, Presti JC
- Issue date: 2018 Jan
- Tissue-based Genomics Augments Post-prostatectomy Risk Stratification in a Natural History Cohort of Intermediate- and High-Risk Men.
- Authors: Ross AE, Johnson MH, Yousefi K, Davicioni E, Netto GJ, Marchionni L, Fedor HL, Glavaris S, Choeurng V, Buerki C, Erho N, Lam LL, Humphreys EB, Faraj S, Bezerra SM, Han M, Partin AW, Trock BJ, Schaeffer EM
- Issue date: 2016 Jan
- Comparing Prognostic Utility of a Single-marker Immunohistochemistry Approach with Commercial Gene Expression Profiling Following Radical Prostatectomy.
- Authors: Leapman MS, Nguyen HG, Cowan JE, Xue L, Stohr B, Simko J, Cooperberg MR, Carroll PR
- Issue date: 2018 Nov
- The Role of Prostate-specific Antigen Persistence After Radical Prostatectomy for the Prediction of Clinical Progression and Cancer-specific Mortality in Node-positive Prostate Cancer Patients.
- Authors: Bianchi L, Nini A, Bianchi M, Gandaglia G, Fossati N, Suardi N, Moschini M, Dell'Oglio P, Schiavina R, Montorsi F, Briganti A
- Issue date: 2016 Jun
- A genomic classifier improves prediction of metastatic disease within 5 years after surgery in node-negative high-risk prostate cancer patients managed by radical prostatectomy without adjuvant therapy.
- Authors: Klein EA, Yousefi K, Haddad Z, Choeurng V, Buerki C, Stephenson AJ, Li J, Kattan MW, Magi-Galluzzi C, Davicioni E
- Issue date: 2015 Apr